Oestrogen levels could be affected.
As I understand it, randomised trials show that oestrogen replacement substantially or totally prevents post-menopause bone loss. Tamoxifen is an antioestrogen agent. Has the osteoporotic value been , explained to women volunteering for the four-year tamoxifen trials mentioned in Nursing Standard on October 18 (News)?
Brighton.
Ros
R
Mason